Parecoxib sodium on anti-inflammatory and postoperative analgesia in patients undergoing lobectomy

SUN Li-xin,ZHANG Yan-ping,HOU Nian-guo,Yu Yang,SHI Fei,WANG Ming-shan
DOI: https://doi.org/10.3969/j.issn.1001-6821.2013.02.011
2013-01-01
Abstract:Objective To investigate parecoxib sodium on inflammatory factors and postoperative analgesia in patients undergoing lobectomy.Methods Forty patients were randomly allocated to parecoxib group(group P,n=20) and control group(group C,n=20).Group P received intravenous parecoxib 40 mg before anesthesia induction,and received intravenous parecoxib 40 mg at 12,24 and 36 h after the first dose.At the same time,group C received intravenous normal saline respectively.The following indexes were recorded at 12,24,36 and 48 h after the operation:VAS scores of pain,sedation score,delivery,drug dose,and side effects.Venous blood samples were taken before anesthesia induction,at the end of operation,at 12 h and 24 h after operation for determination of serum IL-6,IL-8 and TNF-α concentrations.Results There were no significant difference in VAS scores(P>0.05).Sedation score,delivery and drug dose in group P were significantly lower than in group C after the PCA pumps were used(P<0.05).The incidence of nausea and vomit in group P were significantly lower than in group C(P<0.05).Compared with group C,serum IL-6 concentrations was significantly lower at the end of operation,at 12 h and 24 h after operation in group P,and serum IL-8 and TNF-α concentrations were significantly lower at 12 h and 24 h after operation in group P. Conclusion Parecoxib sodium can relief pain and decrease inflammatory factors levels in patient undergoing lobectomy efficiently.
What problem does this paper attempt to address?